| Literature DB >> 20937318 |
Luciana V Carvalho1, Rita de C Ruiz, Karina Scaramuzzi, Eliana B Marengo, Jivaldo R Matos, Denise V Tambourgi, Marcia C A Fantini, Osvaldo A Sant'Anna.
Abstract
In 2006, the first report of a nanostructured material as adjuvant was described establishing the effectiveness of the ordered mesoporous SBA-15 silica as an immune adjuvant. The present study evaluated the SBA-15 capacity to modulate the immune responsiveness of High and Low responder mice immunized with BSA encapsulated/adsorbed in SBA-15 by the intramuscular or oral route and the adjuvant effect was compared with the responsiveness induced by BSA in aluminum hydroxide salts or emulsified in Incomplete Freund adjuvant. These results demonstrate the ability of the non-toxic SBA-15 nanoparticles to increase the immunogenicity and repair the responsiveness of the constitutively low responder individuals inducing both the IgG2a and the IgG1 isotypes, independently of the immune cell committed and conditioning the low phenotype. This new adjuvant may reveal novel therapeutic targets for immune modulation and vaccine design.Entities:
Mesh：
Substances：
Year: 2010 PMID： 20937318 DOI： 10.1016/j.vaccine.2010.09.087
Source DB: PubMed Journal: Vaccine ISSN： 0264-410X Impact factor: 3.641